Stock Information

• Neurocrine Biosciences, Inc. (NBIX) Soleno Therapeutics, Inc. - M&A Call - Slideshow
  Fri, Apr 10, 2026 7:04 PM
• Morgan Stanley Maintains Equal-Weight on Neurocrine Biosciences, Raises Price Target to $185
  Fri, Apr 10, 2026 11:35 AM
• Neurocrine Biosciences Inc (NASDAQ:NBIX) Emerges as a Top Affordable Growth Stock
  Thu, Apr 9, 2026 8:01 AM
• Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why
  Wed, Apr 8, 2026 3:23 PM
• Assessing Neurocrine Biosciences (NBIX) Valuation As Long Term Returns Outpace A Richer Earnings Multiple
  Tue, Apr 7, 2026 10:11 PM
• Citigroup Maintains Buy on Neurocrine Biosciences, Raises Price Target to $242
  Tue, Apr 7, 2026 2:13 PM
• Neurocrine Soleno Deal Adds Vykat XR And Alters Valuation Story
  Tue, Apr 7, 2026 2:08 PM
• Arm downgraded, Arista Networks upgraded: Wall Street's top analyst calls
  Tue, Apr 7, 2026 1:47 PM
• Company News for Apr 7, 2026
  Tue, Apr 7, 2026 1:33 PM
• Canaccord Genuity Maintains Buy on Neurocrine Biosciences, Raises Price Target to $200
  Tue, Apr 7, 2026 10:24 AM

Financial data not available